Glucocorticoid-resistance in peripheral-blood lymphocytes does not correlate with number or affinity of glucocorticoid-receptors in chronic renal failure patients

Immunopharmacology

Volumn 36, Issue 1, 1997, Pages 57-67

  Hirano, Toshihiko ^a   Horigome, Atsushi ^a   Oka, Kitaro ^a   Takeuchi, Hironori ^b   Yoshida, Masaharu ^b   Sakurai, Etsuo ^b   Kozaki, Koichi ^b   Matsuno, Naoto ^b   Nagao, Takeshi ^b   Kozaki, Masami ^b  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

chronic renal failure; glucocorticoid receptor; glucocorticoid resistance; peripheral blood lymphocytes; renal transplantation

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PREDNISOLONE;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL;

ADULT; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; KIDNEY FAILURE, CHRONIC; LYMPHOCYTES; MALE; PREDNISOLONE; RECEPTORS, GLUCOCORTICOID;

EID: 17144432990     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(96)00163-4     Document Type: Article

References (51)

1. Pieters R, Huismans DR, Loonen AH, Hahlen K, van der Dose-van den Berg A, van Wering ER, Veerman AJP. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet 1991; 338: 399-403.
2. Brown PH, Teelucksingh S, Matusiewicz SP, Greening AP, Crompton GK, Edwards CRW. Cutaneous vasoconstrictor response to glucocorticoids in asthma. Lancet 1991; 337: 576-580.
3. Lowy MT, Reder AT, Meltzer HY. Hypercortisolism and depression. N Engl J Med 1985; 312: 791.
4. Oka K, Shimodaira H. Telepharmacodynamics to predict therapeutic effects of glucocorticoids. Lancet 1991; 338: 385.
5. Dumble LJ, Macdonald IM, Kincaid-Smith P, Clunie GJA. Correlation between ADCC resistance to in vitro steroid and renal allograft failure. Transplant Proc 1981; 13: 1569-1571.
6. Dumble LJ, Clunie GJA, Macdonald IM, Bowes LG, Dowling JPG, Kincaid-Smith P. Diminished incidence of rejection in renal allograft recipients with ADCC sensitive to in vitro steroids. Transplant Proc 1983; 15: 1954-1956.
7. Bowes LG, Dumble LJ, Clunie GJA, Francis DMA, Macdonald IM, Kincaid-Smith P. Lymphoid resistant responses to in vitro immunosuppression in renal transplant recipients: Increased incidence of refractory episodes. Transplant Proc 1988; 20: 20-22.
8. Dumble LJ, Bowes LG, Francis DMA, Macdonald IM, Clunie GJA. Pretransplant lymphocyte sensitivity to methylprednisolone. Lancet 1986; i: 291.
9. Langhoff E, Ladefoged J, Jakobsen BK, Platz P, Ryder LP, Svejgaard A, Thaysen JH. Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival. Lancet 1986; ii: 1296-1297.
10. Hirano T, Oka K, Sakurai E, Tamaki T, Kozaki M. Impaired prednisolone sensitivities of endocrine system as well as that of peripheral-blood lymphocytes are closely related to clinical incidence in renal transplantation. J Pharm Pharmacol 1991; 43: 569-573.
11. Kang XX, Hirano T, Oka K, Sakurai E, Tamaki T, Kozaki M. Altered prednisolone-specific lymphocyte sensitivity in chronic renal failure may play a role of pharmacodynamic marker of acute allograft rejection following kidney transplantation. Eur J Clin Pharmacol 1991; 41: 417-423.
12. Hirano T, Oka K, Takeuchi H, Sakurai E, Matsuno N, Tamaki T, Kozaki M. Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone. Transplantation 1994; 57: 1342-1348.
13. Norbiato G, Bevilacqua M, Vago T, Baldi G, Chebat E, Bertora P, Moroni M, Galli M, Oldenburg N. Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74: 608-613.
14. Shakhov Y, Petrichenko I, Fuki I. Reduced sensitivity of cultured skin fibroblasts from familial hypercholesterolemic patients to glucocorticoids. Life Sci 1993; 53: 1617-1624.
15. Malchoff DM, Brufsky A, Reardon G, McDermott P, Javier EM, Bergh C.-H, Rowe D, Malchoff CD. A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest 1993; 91: 1918-1925.
16. Sher ER, Leung DYM, Surs W, Kam JC, Zieg G, Kamada AK, Szefler SJ. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994; 93: 33-39.
17. Ip MM, Shea WK, Sykes D, Young DA. The truncated glucocorticoid receptor in the P1789 mouse lymphosarcoma is associated with resistance to glucocorticoid lysis but not to other glucocorticoid-induced functions. Cancer Res 1991; 51: 2786-2796.
18. Hendry III WJ, Hakkak R, Cornett LE. Selective loss of glucocorticoid-dependent responses in a variant of the DDT1MF-2 tumor cells line. Cancer Res 1992; 52: 2516-2522.
19. Hirano T, Oka K, Tamaki T. Gramicidine as a potential immunosuppressant for organ transplantation. J Pharmacol Exp Ther 1995; 273: 223-229.
20. Hirano T, Oka K, Kawashima E, Akiba M. Effects of synthetic and naturally occurring flavonoids on mitogen-induced proliferation of human peripheral-blood lymphocytes. Life Sci 1989; 45: 1407-1411.
21. Smith KA, Grabtree GR, Kennedy SJ, Munck A. Glucocorticoid receptors and sensitivity of mitogen stimulated and unstimulated lymphocytes. Nature 1977; 267: 523-526.
22. Neifeld JP, Lippman ME, Tormey DC. Steroid hormone receptors in normal human lymphocytes. J Biol Chem 1977; 252: 2972-2977.
23. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai J-J, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma: Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991; 144: 1016-1025.
24. Lane SJ, Lee TH. Glucocorticoid receptor characteristics in monocytes of patients with corticosteroid-resistant bronchial asthma. Am Rev Respir Dis 1991; 143: 1020-1025.
25. Tanaka H, Akama H, Ichikawa Y, Homma M, Oshima H. Glucocorticoid receptors in normal leukocytes: Effects of age, gender, season, and plasma cortisol concentrations. Clin Chem 1991; 37: 1715-1719.
26. Gambertoglio JG, Amend WJJr, Benet LZ. Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: A review. J Pharmacokinet Biopharm 1980; 8: 1-52.
27. Ost L, Bjorkhem I, von Bahr C. Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation. Eur J Clin Pharmacol 1984; 26: 363-369.
28. r receptors in end-stage renal failure. N Engl J Med 1990; 322: 717-722.
29. Heslan JM, Lautie JP, Intrator L, Blanc C, Lagrue G, Sobel AT. Impaired IgG synthesis in patients with the nephrotic syndrome. Clin Nephrol 1982; 18: 144-147.
30. Osakabe K, Matsumoto K. Concanavalin A-induced suppressor cell activity in lipoid nephrosis. Scand J Immunol 1981; 14: 161-166.
31. Shalhoub RJ. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974; ii: 556-560.
32. Newberry WM, Sanford JP. Defective cellular immunity in renal failure: Depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest 1971; 50: 1262-1271.
33. Schnaper HW, Aune TM. Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children. J Clin Invest 1985; 76: 341-349.
34. Kang XX, Hirano T, Oka K, Tamaki T, Sakurai E, Kaji N, Yoshida M, Kozaki M. Recovery of decreased ability of peripheral-blood mononuclear cells from chronic renal failure to produce interleukin-1 α and β after renal transplantation. Nephron 1991; 58: 450-455.
35. Bowes LG, Dumble LJ, Clunie GJA, MacDonald IM, Kinkaid-Smith P. Blood transfusion induction of immuno-suppressant-resistant lymphoid populations in dialysis patients. Transplant Proc 1987; 19: 2863-2864.
36. Barna BP, Makker S, Kallen R, Valenzuela R, Deodhar SD, Yeip M, Leto D, Verbic MA, Rajaraman S, Govindarajan S. A lymphocytotoxic factor(s) in plasma of patients with minimal change nephrotic syndrome: Partial characterization. Clin Immunol Immunopathol 1983; 27: 272-282.
37. Martini A, Viello MA, Siena S, Capalli V, Ugazio AG. Multiple serum inhibitors of lectin-induced lymphocyte proliferation in nephrotic syndrome. Clin Exp Immunol 1981; 45: 178-184.
38. Beale MG, Hoffsten PE, Robson AM, Macdermott RP. Inhibitory factor of lymphocyte transformation in sera from patients with minimal change nephrotic syndrome. Clin Nephrol 1980; 13: 271-276.
39. Iitaka K, West CD. A serum inhibitor of blastogenesis in idiopathic nephrotic syndrome transformed by lymphocytes. Clin Immunol Immunopathol 1979; 12: 62-71.
40. Moorthy AV, Zimmerman SW, Burkholder PM. Inhibition of lymphocyte blastogenesis of patients with minimal change nephrotic syndrome. Lancet 1976; i: 1160-1162.
41. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995; 95: 2435-2441.
42. Walker KB, Potter JM, House AK. Interleukin 2 synthesis in the presence of steroids: A model of steroid resistance. Clin Exp Immunol 1987; 68: 162-167.
43. Becker B, Shin DH, Palmberg PF, Waltman SR. HLA antigens and corticosteroid response. Science 1976; 194: 1427-1428.
44. Bultley MS, Erickson RP, Pratt WB. Hepatic glucocorticoid receptors and the H2 locus. Nature 1978; 275: 136-138.
45. Gupta C, Goldman A. H2 histocompatibility region: Influence on the murine glucocorticoid receptor and its response. Science 1982; 216: 994-996.
46. Erickson RP, Heidel L, Kapur JJ, Karolyi JM, Odenheimer DJ, Pairitz GL, Schultz JS, Sing CF. HLA antigens, phytohemagglutinin stimulation, and corticosteroid resistance. Am J Hum Genet 1985; 37: 761-770.
47. Salmela K, von Willebrand E, Kyllonen L, Koskimies S, Isoniemi H, Eklund B, Hockerstedt, Ahonen J. HLA-DR1, -DR5, and -DR8 antigen disparities are associated with acute steroid-resistant rejection and poor kidney graft survival. Transplant Proc 1991; 23: 1272-1273.
48. Pukhalsky AL, Kalashnikova EA, Lyashko VN, Pevnitsky LA. Inhibition of phytohemagglutinin-induced lymphocyte proliferation by dexamethasone: Mechanisms of individual susceptibility. Int J Immunopharmac 1990; 12: 657-663.
49. Pratt WB. Interaction of hsp 90 with steroid receptors: Organizing some diverse observations and presenting the newest concepts. Mol Cell Endocrinol 1990; 74: C69-C76.
50. Nakayama K, Nakayama K, Negishi I, Kuida K, Shinkai Y, Louie MC, Fields LE, Lucas PJ, Stewart V, Alt FW, Loh DY. Disappearance of the lymphoid system in bcl-2 homozygous mutant chimeric mice. Science 1993; 261: 1584-1587.
51. Klein A, Bessler H, Hoogervorst-Spalter H, Kaufman H, Djaldetti M, Joshua H. A difference between human B and T lymphocytes regarding their capacity to metabolize cortisol. J Steroid Biochem 1980; 13: 517-520.